Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2025-11-25 | PAULSON & CO. INC. | - | Buy | 2,500,000 | $6.25 | $15,625,000.00 | +3.5% | → |
| 2025-09-08 | Carson Seana | EVP, General Counsel | Sell | 13,370 | $7.31 | $97,734.70 | -2.6% | → |
| 2025-08-21 | Lee Frank D. | Director | Sell | 15,912 | $7.66 | $121,885.92 | -17.7% | → |
| 2025-08-14 | Paulson John | - | Buy | 34,721,118 | $9.00 | $312,490,062.00 | +96.4% | → |
| 2025-08-13 | Paulson John | - | Buy | 3,243,049 | $6.56 | $21,267,730.74 | +3.1% | → |
| 2025-06-13 | Paulson John | - | Buy | 3,564,059 | $5.94 | $21,170,510.46 | +12.2% | → |
| 2025-06-12 | Paulson John | - | Buy | 2,788,608 | $5.27 | $14,700,256.94 | +3.4% | → |
| 2024-12-02 | Carson Seana | EVP, General Counsel | Sell | 440 | $8.35 | $3,674.00 | -0.1% | → |
| 2024-09-06 | Carson Seana | EVP, General Counsel | Sell | 13,370 | $6.21 | $83,027.70 | -3.0% | → |
| 2024-03-04 | Carson Seana | EVP, General Counsel | Sell | 6,313 | $9.80 | $61,867.40 | -0.3% | → |
| 2023-12-05 | Carson Seana | EVP, General Counsel | Sell | 220 | $7.38 | $1,623.60 | - | → |
| 2023-11-06 | Carson Seana | EVP, General Counsel | Sell | 43 | $7.61 | $327.23 | - | → |
| 2023-09-06 | Carson Seana | EVP, General Counsel | Sell | 6,685 | $8.28 | $55,351.80 | -1.7% | → |
| 2023-02-28 | Carson Seana | EVP, General Counsel | Sell | 292 | $9.32 | $2,721.44 | - | → |
| 2022-04-14 | Spurr Robert | U.S. President-Pharma Business | Sell | 1,595 | $22.19 | $35,393.05 | -1.7% | → |
| 2022-03-15 | Spurr Robert | U.S. President-Pharma Business | Sell | 4,846 | $22.20 | $107,581.20 | -5.0% | → |
| 2022-03-08 | Gordon Joseph F | Pres&Co-Head Bausch&Lomb/Int'l | Sell | 3,889 | $21.76 | $84,624.64 | -4.0% | → |
| 2022-03-02 | Gordon Joseph F | Pres&Co-Head Bausch&Lomb/Int'l | Sell | 11,077 | $23.37 | $258,869.49 | -9.9% | → |
| 2022-03-02 | Spurr Robert | U.S. President-Pharma Business | Sell | 1,595 | $23.37 | $37,275.15 | -2.4% | → |
| 2022-03-01 | Gordon Joseph F | Pres&Co-Head Bausch&Lomb/Int'l | Sale+OE | 6,338 | $23.82 | $150,971.16 | -5.3% | → |
| 2022-02-15 | Spurr Robert | U.S. President-Pharma Business | Sell | 3,251 | $25.02 | $81,340.02 | -5.1% | → |
| 2022-01-18 | Spurr Robert | U.S. President-Pharma Business | Sell | 3,251 | $26.63 | $86,574.13 | -4.9% | → |
| 2021-11-30 | Miller Steven D | Director | Buy | 60,000 | $24.23 | $1,453,524.00 | +556.6% | → |
| 2021-08-05 | VON ESCHENBACH ANDREW C. | Director | Buy | 1,400 | $25.94 | $36,316.00 | +3.8% | → |
| 2021-08-04 | DE SCHUTTER RICHARD U | Director | Buy | 10,000 | $25.01 | $250,123.00 | +3.3% | → |
| 2021-06-11 | Eldessouky Sam | EVP & Chief Financial Officer | Sell | 17,000 | $31.68 | $538,585.50 | -12.7% | → |
| 2021-06-02 | ACKERMANN CHRISTINA | EVP AND GENERAL COUNSEL | Sale+OE | 121,198 | $31.83 | $3,857,732.34 | -42.1% | → |
| 2021-05-26 | WECHSLER AMY B | Director | Sell | 11,037 | $31.79 | $350,811.05 | -10.1% | → |
| 2020-12-04 | Humphries William D. | President, Ortho-Dermatologics | Sale+OE | 114,055 | $19.87 | $2,266,398.31 | -32.7% | → |
| 2020-11-27 | Humphries William D. | President, Ortho-Dermatologics | Sale+OE | 36,804 | $19.63 | $722,519.22 | -5.0% | → |
| 2020-09-08 | Humphries William D. | President, Ortho-Dermatologics | Sell | 5,667 | $16.17 | $91,635.39 | -2.4% | → |
| 2020-06-05 | ValueAct Holdings, L.P. | Director, See Remarks | Sell | 948,353 | $19.24 | $18,246,311.72 | -100% | → |
| 2020-06-05 | ValueAct Holdings, L.P. | Director, See Remarks | Buy | 948,353 | $19.24 | $18,246,311.72 | +5.6% | → |
| 2020-05-14 | Paulson John | - | Buy | 2,958,964 | $16.16 | $47,830,453.80 | +1.8% | → |